Bull&Bear | Eason Technology Leads Gains with 168% Surge; Tectonic Suffers 40.65% Drop Amid Eli Lilly's Kidney Drug Update

In the realm of rising stocks, Eason Technology saw a significant surge of 168%. This was primarily driven by the company's release of an optimistic quarterly financial report, which showed substantial growth in both revenue and profits. Additionally, Eason announced a new technology collaboration agreement that aims to further expand its market share.

Diginex experienced a 59.13% increase, marking a consecutive two-day rise, with a total increase of 75.32% over the past two days. Diginex, hailing from Hong Kong, successfully debuted in the U.S. IPO market and doubled in value over two days.

Planet Image saw its stock rise by 66.88%, continuing a two-day upward trend with a cumulative increase of 139.07% over those two days. The rise followed the company's report of significant sales growth in the first half of the year.

Monopar Therapeutics soared by 24.76% after Citibank maintained its buy rating on the company and increased its price target to $40.

WLS Holdings surged 18.17%, marking a three-day consecutive rise with an aggregate increase of 22.24%. This came after WLS Holdings announced the capitalization of its current shares.

Conversely, in the declining stocks segment, Tectonic experienced a drop of 40.65%, continuing a two-day downward trend with a total decrease of 47.71%. This was attributed to the impact of Eli Lilly's update on their kidney drug trial on Tectonic.

JetBlue Airlines fell by 25.71%, as analysts pointed out potential engine-related issues that may cause further flight groundings in 2025 and 2026, adversely affecting capacity.

Nextera Energy saw its shares decline by 25.19% following the suspension of distribution by XPLR.

Quantum had a downturn of 16.08%, marking a five-day consecutive slide with a cumulative drop of 32.80%. Lake Street rated Quantum as a hold.

Transcat experienced a 12.71% decline, continuing a five-day downward trend with a total decrease of 17.26%. The company reported a decrease in adjusted earnings for the third quarter of the fiscal year, despite a rise in operating income, leading to a post-market drop in stock price.